Michel Hochuli

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation.

Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation.

Journal: Molecular genetics and metabolism reports

Published: May 19, 2026

Brain Age in Adult Patients With Early-Treated Phenylketonuria.

Brain Age in Adult Patients With Early-Treated Phenylketonuria.

Journal: Journal of inherited metabolic disease

Published: August 28, 2025

Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity - A randomized clinical trial.

Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity - A randomized clinical trial.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: January 16, 2025

Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

Journal: Molecular genetics and metabolism

Published: January 15, 2025

The influence of menstrual cycle on metabolic control and diet in patients with phenylketonuria.

The influence of menstrual cycle on metabolic control and diet in patients with phenylketonuria.

Journal: Orphanet journal of rare diseases

Published: November 23, 2024

Reversible white matter changes following a 4-week high phenylalanine exposure in adults with phenylketonuria.

Reversible white matter changes following a 4-week high phenylalanine exposure in adults with phenylketonuria.

Journal: Journal of inherited metabolic disease

Published: August 20, 2024

Effect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.

Effect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.

Journal: NeuroImage. Clinical

Published: May 28, 2024

Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria.

Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria.

Journal: Brain : a journal of neurology

Published: December 18, 2023

Cerebral blood flow and white matter alterations in adults with phenylketonuria.

Cerebral blood flow and white matter alterations in adults with phenylketonuria.

Journal: NeuroImage. Clinical

Published: September 08, 2023

Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial.

Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial.

Journal: The American journal of clinical nutrition

Published: April 03, 2023

Health-related quality of life in a european sample of adults with early-treated classical PKU.

Health-related quality of life in a european sample of adults with early-treated classical PKU.

Journal: Orphanet journal of rare diseases

Published: January 04, 2023

Compromised white matter is related to lower cognitive performance in adults with phenylketonuria.

Compromised white matter is related to lower cognitive performance in adults with phenylketonuria.

Journal: Brain communications

Published: December 23, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026